Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Roulia P, Mantalovas S, Dagher M, Karakousis AV, Varsamis N, Vlassopoulos K, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: anestakis d. Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455. Pharmaceutics. 2024. PMID: 38675116 Free PMC article. Review.
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Dagher M, Karakousis VA, Varsamis N, Theodorou V, Mystakidou CM, Vlassopoulos K, Kosmidis S, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: anestakis d. Front Immunol. 2024 Jan 16;14:1325360. doi: 10.3389/fimmu.2023.1325360. eCollection 2023. Front Immunol. 2024. PMID: 38292487 Free PMC article. Review.
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Dagher M, Varsamis N, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: anestakis d. Pharmaceutics. 2023 Oct 13;15(10):2458. doi: 10.3390/pharmaceutics15102458. Pharmaceutics. 2023. PMID: 37896218 Free PMC article. Review.
Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver.
Al Mogrampi S, Boumpoureka C, Afaloniati H, Lagou M, Angelopoulou K, Anestakis D, Tampouratzi ZG, Iliadis S, Antoniadis N, Giakoustidis A, Papalois A, Papadopoulos V, Poutahidis T, Giakoustidis D. Al Mogrampi S, et al. Among authors: anestakis d. J Clin Med. 2023 Feb 22;12(5):1751. doi: 10.3390/jcm12051751. J Clin Med. 2023. PMID: 36902538 Free PMC article.
Congenital Supratentorial Neuroectodermal Primary Tumor: A Rare Embryonal Tumor With an Uncommon Clinical Presentation.
Giovannopoulou E, Karakasi MV, Nikolaidis I, Anestakis D, Deftereos S, Blontzos N, Grigoriadis N, Pavlidis P. Giovannopoulou E, et al. Among authors: anestakis d. Am J Forensic Med Pathol. 2022 Dec 1;43(4):e96-e100. doi: 10.1097/PAF.0000000000000775. Epub 2022 Jun 9. Am J Forensic Med Pathol. 2022. PMID: 36377857 No abstract available.
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, Eskitzis P, Zarogoulidis P, Kosmidis C, Matthaios D, Porpodis K. Katopodi T, et al. Among authors: anestakis d. Front Oncol. 2022 Oct 21;12:1042125. doi: 10.3389/fonc.2022.1042125. eCollection 2022. Front Oncol. 2022. PMID: 36338748 Free PMC article. Review.
Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report.
Skoura R, Andronikidi PE, Anestakis D, Petanidis S, Orovou E, Tzitiridou M, Eskitzis P. Skoura R, et al. Among authors: anestakis d. Cureus. 2022 Aug 27;14(8):e28458. doi: 10.7759/cureus.28458. eCollection 2022 Aug. Cureus. 2022. PMID: 36176850 Free PMC article.
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity.
Domvri K, Petanidis S, Zarogoulidis P, Anestakis D, Charalampidis C, Tsavlis D, Huang H, Freitag L, Hohenforst-Schmidt W, Matthaios D, Katopodi T, Porpodis K. Domvri K, et al. Among authors: anestakis d. Int J Nanomedicine. 2022 Sep 22;17:4449-4468. doi: 10.2147/IJN.S346341. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36172007 Free PMC article.
29 results